Company

Companies of New York

Genprex

Genprex

Healthcare

Connections 1

Subscribe To favorites

Description

Genprex, Inc. is a clinical-stage gene therapy company focused on developing treatments for cancer and diabetes.

The Company's lead cancer drug candidate, REQORSA Immunogene therapy drug (also referred to as GPX-001), is being developed to treat non-small cell lung cancer (NSCLC). The active agent in REQORSA is a TUSC2 gene expressing plasmid that is encapsulated in a DOTAP cholesterol nanoparticle. TUSC2 is a tumor suppressor gene which has both tumor killing (via apoptosis) and immunomodulatory effects.

The Company utilizes its ONCOPREX Nanoparticle Delivery System to deliver the TUSC2 gene expressing plasmid to cancer cells. Its diabetes gene therapy, also referred to as GPX-002, is designed to work by transforming alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body's immune system.

Website

https://www.genprex.com

Rating GlobalNY.biz

Mentions in the news View all

Quotes

All

NASA Names Astronaut Christina Koch Acting Deputy Chief Engineer

ISAACMAN Jared
ISAACMAN Jared

Christina has seen NASA engineering from both sides of the equation: developing complex systems on the ground and trusting them with her life in space

Blondie Reopens Its New York Story With High Noon

HARRY Deborah
HARRY Deborah

This music feels grounded in the present, shaped by who we are and how we’re living now

Pedro Pascal Discovers His Most Intimidating Co-Star Is a Cello

PASCAL Pedro
PASCAL Pedro

I’d never been so afraid

Paul Bettany Reveals the Call That Rebuilt His Hollywood Career

BETTANY Paul
BETTANY Paul

Maybe my career is over

Matthew Lillard Says Cult Fame Still Has Not Won Hollywood’s Trust

LILLARD Matthew
LILLARD Matthew

Nobody ever equates me with greatness